FDA: ADHD drug use should continue despite study on sudden death

06/16/2009 | Wall Street Journal, The

The FDA said children with attention-deficit/hyperactivity disorder should continue taking medications for their condition because there is no sufficient evidence that the drugs cause sudden death. The warning follows a study partly funded by the agency that cites 10 cases of sudden death in the patient group taking stimulants.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX